Biovet JSC (LTS:0III) Market Cap: лв0.00 Mil (As of Jun. 30, 2026)


What is Biovet JSC Market Cap?

Biovet JSC LTS:0III Market Cap is лв0.00 Mil as of Jun. 30, 2026. The stock has 1 warning sign investors should review.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Biovet JSC's share price for the quarter that ended in Dec. 2016 was лв0. Biovet JSC's Shares Outstanding (EOP) for the quarter that ended in Dec. 2016 was 6.78 Mil. Therefore, Biovet JSC's market cap for the quarter that ended in Dec. 2016 was лв0.00 Mil.

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Biovet JSC's Enterprise Value for Today is лв0.00 Mil.

Biovet JSC  (LTS:0III) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Biovet JSC Market Cap Related Terms

Biovet JSC Market Cap Historical Data

* Premium members only.

The historical data trend for Biovet JSC's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biovet JSC Market Cap Chart

Biovet JSC Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Market Cap
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Biovet JSC Quarterly Data
Dec09 Dec10 Dec11 Dec12 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

LTS:0III vs ADMP, AGRX, BUDZ: Market Cap Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Biovet JSC's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biovet JSC Market Cap vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biovet JSC's Market Cap distribution charts can be found below:

* The bar in red indicates where Biovet JSC's Market Cap falls into.


Biovet JSC Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Biovet JSC's Market Cap for the fiscal year that ended in Dec. 2016 is calculated as

Market Cap (A: Dec. 2016 )=Share Price (A: Dec. 2016 )*Shares Outstanding (EOP) (A: Dec. 2016 )
=лв0*6.780
=лв

Biovet JSC's Market Cap for the quarter that ended in Dec. 2016 is calculated as

Market Cap (Q: Dec. 2016 )=Share Price (Q: Dec. 2016 )*Shares Outstanding (EOP) (Q: Dec. 2016 )
=лв0*6.783
=лв0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of лв0.00 Mil mean?
Biovet JSC (LTS:0III) has a Market Cap of лв0.00 Mil as of Jun. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Biovet JSC and its competitors.
Is Biovet JSC's Market Cap too high?
Biovet JSC's current Market Cap is лв0.00 Mil.
How does Biovet JSC's Market Cap compare to ADMP and AGRX?
Biovet JSC's Market Cap of лв0.00 Mil can be compared against companies in the Drug Manufacturers industry. The industry median Market Cap is 213.67. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 213.67, based on 1,020 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Biovet JSC and its competitors. For the Drug Manufacturers industry, the median Market Cap is 213.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biovet JSC's current Market Cap is лв0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biovet JSC stock overvalued right now?
Biovet JSC (LTS:0III) has a current Market Cap of лв0.00 Mil. The current Market Cap is лв0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Biovet JSC (LTS:0III), the current Market Cap is лв0.00 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biovet JSC Business Description

Biovet JSC manufactures & markets medicated and nutritional feed additives, enzymes, bulk active substances & pharmaceuticals for animal productivity & health. It offers intermediates, active ingredients and medicines for human pharmaceutical industry.